SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amerise Biosciences - Quaterly Results

22 Jan 2024 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended December 2023, as compared to corresponding quarter of last year.The Net Loss for the quarter ended December 2023 is Rs. -0.61 millions as compared to Net Loss of Rs. -0.52 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 further decreased to -0.61% as compared to -0.52% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.03 0.00 0.09 95.77 -99.91
Other Income 0.00 0.00 0.00 0.00 0.06 0.00 0.00 0.00 0.00
PBIDT -0.61 -0.52 17.31 -1.67 -0.98 70.41 -1.19 5.48 -121.72
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.61 -0.52 17.31 -1.67 -0.98 70.41 -1.19 5.48 -121.72
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.61 -0.52 17.31 -1.67 -0.98 70.41 -1.19 5.48 -121.72
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.61 -0.52 17.31 -1.67 -0.98 70.41 -1.19 5.48 -121.72
Equity 66.07 66.07 0.00 66.07 66.07 0.00 66.07 66.07 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 -3266.67 0.00 -1322.22 5.72 -23207.69

Amerise Biosciences Share Price

0.72 0.03 (4.35%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×